{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:36:58Z","timestamp":1765949818100,"version":"3.48.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00520-025-10213-5","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T23:34:01Z","timestamp":1764200041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of body weight changes on adverse events and treatment outcomes during R-CHOP chemotherapy for non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2147-3150","authenticated-orcid":false,"given":"Hideyuki","family":"Kushihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moeka","family":"Osumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuko","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoe","family":"Kushihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"10213_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.clnu.2016.12.003","volume":"36","author":"P Caillet","year":"2017","unstructured":"Caillet P, Liuu E, Raynaud AS et al (2017) Association between cachexia, chemotherapy, and outcomes in older cancer patients: a systematic review. Clin Nutr 36:1473\u20131482. https:\/\/doi.org\/10.1016\/j.clnu.2016.12.003","journal-title":"Clin Nutr"},{"key":"10213_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1532-5415.1995.tb05803.x","volume":"43","author":"JI Wallace","year":"1995","unstructured":"Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA (1995) Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc 43:329\u2013337. https:\/\/doi.org\/10.1111\/j.1532-5415.1995.tb05803.x","journal-title":"J Am Geriatr Soc"},{"key":"10213_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","volume":"34","author":"HJ Andreyev","year":"1998","unstructured":"Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503\u2013509. https:\/\/doi.org\/10.1016\/S0959-8049(97)10090-9","journal-title":"Eur J Cancer"},{"key":"10213_CR4","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1245\/s10434-014-4296-z","volume":"22","author":"T Aoyama","year":"2015","unstructured":"Aoyama T, Kawabe T, Fujikawa H et al (2015) Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol 22:2560\u20132566. https:\/\/doi.org\/10.1245\/s10434-014-4296-z","journal-title":"Ann Surg Oncol"},{"key":"10213_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/eji.201646423","volume":"47","author":"S Cohen","year":"2017","unstructured":"Cohen S, Danzaki K, MacIver NJ (2017) Nutritional effects on T-cell immunometabolism. Eur J Immunol 47:225\u2013235. https:\/\/doi.org\/10.1002\/eji.201646423","journal-title":"Eur J Immunol"},{"key":"10213_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/0884533616637949","volume":"31","author":"J Girke","year":"2016","unstructured":"Girke J, Seipt C, Markowski A et al (2016) Quality of life and nutrition condition of patients improve under home parenteral nutrition: an exploratory study. Nutr Clin Pract 31:659\u2013665. https:\/\/doi.org\/10.1177\/0884533616637949","journal-title":"Nutr Clin Pract"},{"key":"10213_CR7","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/ijc.23344","volume":"122","author":"EV Willett","year":"2008","unstructured":"Willett EV, Morton LM, Hartge P et al (2008) Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 122:2062\u20132070. https:\/\/doi.org\/10.1002\/ijc.23344","journal-title":"Int J Cancer"},{"key":"10213_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569\u2013578. https:\/\/doi.org\/10.1016\/S0140-6736(08)60269-X","journal-title":"Lancet"},{"key":"10213_CR9","first-page":"5607","volume":"19","author":"YH Chin","year":"1999","unstructured":"Chin YH, Liu JM, Tai JJ et al (1999) The significance of body weight change in non-Hodgkin\u2019s lymphoma. Anticancer Res 19:5607\u20135610","journal-title":"Anticancer Res"},{"key":"10213_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1467-789x.2001.00040.x","volume":"2","author":"RL Kolotkin","year":"2001","unstructured":"Kolotkin RL, Meter K, Williams GR (2001) Quality of life and obesity. Obes Rev 2:219\u2013229. https:\/\/doi.org\/10.1046\/j.1467-789x.2001.00040.x","journal-title":"Obes Rev"},{"key":"10213_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 346:235\u2013242. https:\/\/doi.org\/10.1056\/NEJMoa011795","journal-title":"N Engl J Med"},{"key":"10213_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/etm.2010.175","volume":"2","author":"Y Toiyama","year":"2011","unstructured":"Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M (2011) Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med 2:95\u2013101. https:\/\/doi.org\/10.3892\/etm.2010.175","journal-title":"Exp Ther Med"},{"key":"10213_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"10213_CR14","first-page":"123","volume":"2","author":"FD Ottery","year":"1994","unstructured":"Ottery FD (1994) Cancer cachexia: prevention, early diagnosis and management. Cancer Pract 2:123\u2013131","journal-title":"Cancer Pract"},{"key":"10213_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KCH Fearon","year":"2012","unstructured":"Fearon KCH, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16:153\u2013166. https:\/\/doi.org\/10.1016\/j.cmet.2012.06.011","journal-title":"Cell Metab"},{"key":"10213_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF (2016) Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev 30:489\u2013501. https:\/\/doi.org\/10.1101\/gad.276733.115","journal-title":"Genes Dev"},{"key":"10213_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2442116","volume":"14","author":"H Kawachi","year":"2025","unstructured":"Kawachi H, Yamada T, Tamiya M et al (2025) Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of \u226550% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy. Oncoimmunology 14:2442116. https:\/\/doi.org\/10.1080\/2162402X.2024.2442116","journal-title":"Oncoimmunology"},{"key":"10213_CR18","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1111\/j.1440-1746.2007.05152.x","volume":"23","author":"ABC Crumley","year":"2008","unstructured":"Crumley ABC, Stuart RC, McKernan M, McDonald AC, McMillan DC (2008) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-PS) in patients receiving palliative chemotherapy for gastroesophageal cancer. J Gastroenterol Hepatol 23:e325\u2013e329. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05152.x","journal-title":"J Gastroenterol Hepatol"},{"key":"10213_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-489","volume":"11","author":"JE Hwang","year":"2011","unstructured":"Hwang JE, Kim HN, Kim DE et al (2011) Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer 11:489. https:\/\/doi.org\/10.1186\/1471-2407-11-489","journal-title":"BMC Cancer"},{"key":"10213_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7861\/clinmedicine.6-2-140","volume":"6","author":"GD Stewart","year":"2006","unstructured":"Stewart GD, Skipworth RJE, Fearon KCH (2006) Cancer cachexia and fatigue. Clin Med 6:140\u2013143. https:\/\/doi.org\/10.7861\/clinmedicine.6-2-140","journal-title":"Clin Med"},{"key":"10213_CR21","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1136\/bmjspcare-2020-002296","volume":"12","author":"M Cong","year":"2022","unstructured":"Cong M, Song C, Xu H et al (2022) The patient-generated subjective global assessment is a promising screening tool for cancer cachexia. BMJ Support Palliat Care 12:e39\u2013e46. https:\/\/doi.org\/10.1136\/bmjspcare-2020-002296","journal-title":"BMJ Support Palliat Care"},{"key":"10213_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14283\/jfa.2013.8","volume":"2","author":"TK Malmstrom","year":"2013","unstructured":"Malmstrom TK, Morley JE (2013) Sarcopenia: the target population. J Frailty Aging 2:55\u201356. https:\/\/doi.org\/10.14283\/jfa.2013.8","journal-title":"J Frailty Aging"},{"key":"10213_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/10428194.2015.1056183","volume":"57","author":"K O\u2019Brien","year":"2016","unstructured":"O\u2019Brien K, Luo S, Ganti A et al (2016) Short- and long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy. Leuk Lymphoma 57:313\u2013319. https:\/\/doi.org\/10.3109\/10428194.2015.1056183","journal-title":"Leuk Lymphoma"},{"key":"10213_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/10428194.2016.1217526","volume":"58","author":"DY Xiao","year":"2017","unstructured":"Xiao DY, Luo S, O\u2019Brien K, Liu W, Carson KR (2017) Weight change trends and overall survival in United States veterans with follicular lymphoma treated with chemotherapy. Leuk Lymphoma 58:851\u2013858. https:\/\/doi.org\/10.1080\/10428194.2016.1217526","journal-title":"Leuk Lymphoma"},{"key":"10213_CR25","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146\u2013M156. https:\/\/doi.org\/10.1093\/gerona\/56.3.M146","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10213_CR26","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","volume":"60","author":"RM Collard","year":"2012","unstructured":"Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487\u20131492. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.04054.x","journal-title":"J Am Geriatr Soc"},{"key":"10213_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/gerona\/63.9.984","volume":"63","author":"QL Xue","year":"2008","unstructured":"Xue QL, Bandeen-Roche K, Varadhan R, Zhou J, Fried LP (2008) Initial manifestations of frailty criteria and the development of frailty phenotype in the Women\u2019s Health and Aging Study II. J Gerontol A Biol Sci Med Sci 63:984\u2013990. https:\/\/doi.org\/10.1093\/gerona\/63.9.984","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10213_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.steroids.2014.12.010","volume":"99","author":"JA Cauley","year":"2015","unstructured":"Cauley JA (2015) Estrogen and bone health in men and women. Steroids 99:11\u201315. https:\/\/doi.org\/10.1016\/j.steroids.2014.12.010","journal-title":"Steroids"},{"key":"10213_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.7600\/jpfsm.5.301","volume":"5","author":"A Yuki","year":"2016","unstructured":"Yuki A, Otsuka R, Tange C et al (2016) Epidemiology of frailty in elderly Japanese. J Phys Fit Sports Med 5:301\u2013307. https:\/\/doi.org\/10.7600\/jpfsm.5.301","journal-title":"J Phys Fit Sports Med"},{"key":"10213_CR30","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ejca.2008.02.033","volume":"47","author":"KCH Fearon","year":"2011","unstructured":"Fearon KCH, Arends J, Baracos V (2011) Cancer cachexia: developing multimodal treatment for a multidimensional problem. Eur J Cancer 47:2282\u20132290. https:\/\/doi.org\/10.1016\/j.ejca.2008.02.033","journal-title":"Eur J Cancer"},{"key":"10213_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","volume":"39","author":"DC McMillan","year":"2013","unstructured":"McMillan DC (2013) The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev 39:534\u2013540. https:\/\/doi.org\/10.1016\/j.ctrv.2012.08.003","journal-title":"Cancer Treat Rev"},{"key":"10213_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69. https:\/\/doi.org\/10.1186\/1475-2891-9-69","journal-title":"Nutr J"},{"key":"10213_CR33","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00277-015-2499-4","volume":"94","author":"N Nakamura","year":"2015","unstructured":"Nakamura N, Hara T, Shibata Y et al (2015) Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Ann Hematol 94:2043\u20132053. https:\/\/doi.org\/10.1007\/s00277-015-2499-4","journal-title":"Ann Hematol"},{"key":"10213_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/10428194.2013.816421","volume":"55","author":"H Lanic","year":"2014","unstructured":"Lanic H, Kraut-Tauzia J, Modzelewski R et al (2014) Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 55:817\u2013823. https:\/\/doi.org\/10.3109\/10428194.2013.816421","journal-title":"Leuk Lymphoma"},{"key":"10213_CR35","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s00520-012-1460-5","volume":"20","author":"S Morishita","year":"2012","unstructured":"Morishita S, Kaida K, Tanaka T et al (2012) Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer 20:3161\u20133168. https:\/\/doi.org\/10.1007\/s00520-012-1460-5","journal-title":"Support Care Cancer"},{"key":"10213_CR36","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1200\/jco.2013.54.3926","volume":"32","author":"O Paulsen","year":"2014","unstructured":"Paulsen O, Klepstad P, Rosland JH et al (2014) Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. J Clin Oncol 32:3221\u20133228. https:\/\/doi.org\/10.1200\/jco.2013.54.3926","journal-title":"J Clin Oncol"},{"key":"10213_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","volume":"48","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A (2013) Cancer cachexia: pathophysiology and management. J Gastroenterol 48:574\u2013594. https:\/\/doi.org\/10.1007\/s00535-013-0787-0","journal-title":"J Gastroenterol"},{"key":"10213_CR38","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1517\/14656566.2015.1079621","volume":"16","author":"C Madeddu","year":"2015","unstructured":"Madeddu C, Mantovani G, Gramignano G, Macci\u00f2 A (2015) Advances in pharmacologic strategies for cancer cachexia. Expert Opin Pharmacother 16:2163\u20132177. https:\/\/doi.org\/10.1517\/14656566.2015.1079621","journal-title":"Expert Opin Pharmacother"},{"key":"10213_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/apjon.apjon_68_18","volume":"6","author":"T Naito","year":"2019","unstructured":"Naito T (2019) Evaluation of the true endpoint of clinical trials for cancer cachexia. Asia Pac J Oncol Nurs 6:227\u2013233. https:\/\/doi.org\/10.4103\/apjon.apjon_68_18","journal-title":"Asia Pac J Oncol Nurs"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10213-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10213-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10213-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:32:12Z","timestamp":1765949532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10213-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10213"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10213-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of de-identified data from hospital medical records was approved by the Clinical Research Review Board of the Japanese Red Cross Aichi Medical Center, Nagoya Daiichi Hospital (Approval No. 2024\u2013079).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. This study adhered to the Ethical Guidelines for Medical and Biological Research Involving Human Subjects set forth by the Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labor and Welfare, and Ministry of Economy, Trade and Industry of Japan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Patient consent was obtained using the opt-out method, in accordance with the Clinical Research Review Board guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1139"}}